Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
20 Leser
Artikel bewerten:
(0)

Earnings, Upcoming Results, and Dividend Declaration - Research Reports on L-3, Pentair, Honeywell, Danaher and Emerson

NEW YORK, August 5, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding L-3 Communications Holdings Inc. (NYSE: LLL), Pentair PLC (NYSE: PNR), Honeywell International Inc. (NYSE: HON), Danaher Corp. (NYSE: DHR) and Emerson Electric Co. (NYSE: EMR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5446-100free.

L-3 Communications Holdings Inc. Research Reports

On July 31, 2014, L-3 Communications Holdings Inc. (L-3) announced its preliminary Q2 FY 2014 financial results (period ended June 27, 2014). Consolidated net sales were $3.0 billion, down 5.7%, YoY. Net income attributable to L-3 fell 13.8% YoY to $156 million and diluted EPS decreased 12.1% YoY to $1.75 from $1.99. Book-to-bill ratio was reported to be 1.08, with funded orders of $3.3 billion and funded backlog of $10.7 billion. The Company also updated FY 2014 revenue and earnings guidance. L-3 now expects net sales of $12.03 billion to $12.23 billion, up from $11.95 billion to $12.15 billion, predicted earlier on May 1, 2014. Diluted EPS are expected to be in the range of $7.90 to $8.10 from $8.20 to $8.40 forecasted earlier. Following the announcement, shares of L-3 plunged 12.27% to end the trading session at $104.96 at the close of July 31, 2014 trading session. The full research reports on L-3 are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/LLL/report.pdf

Pentair PLC Research Reports

On July 31, 2014, Pentair PLC (Pentair) released its Q2 FY 2014 financial results (period ended June 28, 2014). Net sales declined 2.7% YoY to $1.9 billion. Adjusted Q2 2014 diluted EPS were $1.04, as against adjusted EPS of $0.92 in Q2 2013. On July 28, 2014, Pentair's Board of Directors approved a decision to exit its Water Transport business. Pentair also lowered its full year 2014 adjusted EPS guidance to a range of $3.65 - $3.70 from a $3.85 - $4.00, in part reflecting announcement that the decision to exit Water Transport business in Australia. The Company also updated its 2015 EPS target to $4.50 from $5.00 reflecting the exclusion of the Water Transport business, ongoing Energy CapEx deferrals, and lingering economic headwinds. The Company anticipates full year 2014 sales of $7.15 billion, or up approximately 2% over 2013 sales. The full research reports on Pentair are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/PNR/report.pdf

Honeywell International Inc. Research Reports

On July 25, 2014, Honeywell International Inc. (Honeywell) reported that its Board of Directors declared a $0.45 per share regular quarterly dividend on the Company's outstanding common stock. The Company informed that the dividend is payable on September 10, 2014 to shareowners of record at the close of business on August 21, 2014. The full research reports on Honeywell are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/HON/report.pdf

Danaher Corp. Research Reports

On July 17, 2014, Danaher Corp. (Danaher) announced its Q2 FY 2014 financial results (period ended June 27, 2014). Revenues for Q2 FY 2014 were $5 billion, versus $4.7 billion reported during Q2 2013. Core revenues increased 3% YoY. Q2 FY 2014 net earnings were $676.4 million, or $0.95 per share on a diluted basis, as against $616.8 million or $0.87 per diluted share for Q2 2013. Danaher informed a $0.02 per share after-tax gain on the sale of marketable securities is included in Q2 2014 diluted EPS. Looking forward, Danaher anticipates GAAP diluted net EPS for Q3 FY 2014 to be in the range of $0.86 to $0.89. The Company also narrowed its diluted net EPS guidance for the FY 2014 to $3.67 to $3.72 on a GAAP basis. The full research reports on Danaher are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/DHR/report.pdf

Emerson Electric Co. Research Reports

On July 15, 2014, Emerson Electric Co. (Emerson) reported that it will release its Q3 FY 2014 financial results before market opens on August 5, 2014, followed by an investor conference call on the same day, beginning at 2:00 p.m. ET, 1:00 p.m. CT. According to Zacks investment research data, the consensus EPS forecast for Q3 FY 2014 is $1.06. The Company added that a live webcast of the event, along with its replay, will be available on the Company's website. The full research reports on Emerson are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/EMR/report.pdf

About Analysts Review

We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.AnalystsReview.com


SOURCE Analysts Review

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.